Woodford Investment Management (WIM) is seeking to raise an initial £200m for the launch of the Woodford Patient Capital investment trust, a portfolio of 50-100 quoted and unquoted businesses.
Contrary to speculation that manager Neil Woodford's second offering at WIM would focus wholly on biotechnology companies, the trust will invest broadly in firms with "outstanding" intellectual property,...
Main barriers revealed
'Alarming' performance differential
Mixed industry reaction to new appointment
Follows extended period of underperformance
Investor urges fund group to be more cautious on promoting funds
How do you appear online?
CETV could be delayed too
4% said ESG mattered "a lot"